One-time IV penicillin added to standard penicillin for adults with acute tonsillitis, tonsillitis with peritonsillar phlegmon, or peritonsillar abscess
Official title: A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis, Peritonsillar Phlegmon, and Peritonsillar Abscess - A Randomized, Double-Blind, Placebo-Controlled Trial
Run by Aarhus University Hospital · NCT07896226 · Data updated 2026-11-12
A single dose of intravenous benzylpenicillin is given alongside standard oral penicillin to adults with acute tonsillitis, peritonsillar phlegmon, or peritonsillar abscess to see if symptoms improve.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 154 (estimated) |
| Sponsor | Aarhus University Hospital Academic / other |
| Locations | 1 site (Aarhus, Central Jutland) |
| Status | Recruiting |
| Started | November 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07896226 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with clinically verified AT, PP, or PTA treated by incision, without penicillin allergy.
✕Probably not a fit
Patients with penicillin allergy or those in whom the infection does not respond to penicillin may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase 4 trial tests whether adding a single IV dose of benzylpenicillin to usual oral phenoxymethylpenicillin improves outcomes for adults with AT, PP, or PTA treated by incision. Participants receive either the IV antibiotic or a placebo alongside standard care, with measurements focused on pain, symptom burden, analgesic use, complications, and long-term results. The study targets adults without penicillin allergy and seeks to understand if the adjunct reduces treatment failure or progression. The design reflects a pragmatic approach to real-world treatment settings in Denmark. Safety monitoring and ethical considerations are integral components of the protocol.
Why it matters
Potential benefit: If successful, patients may experience faster relief of symptoms and fewer complications.
How similar studies have gone: Previous work by the research group suggests beta-lactam antibiotics are effective, and this trial extends that approach to an adjunct IV dose; the outcome is not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants must meet one of the following clinical criteria: * Clinically verified acute tonsillitis (AT) with a Centor score of 3-4 and without peritonsillar phlegmon (AT group); * Clinical acute tonsillitis (AT) with a Centor score of 3-4 and with peritonsillar phlegmon (PP group); or * Peritonsillar abscess treated by incision (PTA group). Additionally, participants must meet the following criteria: * Written informed consent; * Age ≥18 years. Exclusion Criteria: * Known allergy or hypersensitivity to penicillin; * Pregnancy or planned pregnancy; * Suspected or confirmed spread of infection, including but not limited to: * Parapharyngeal or retropharyngeal abscess * Necrotizing fasciitis * Mediastinitis * Lemierre's syndrome.
Where it's running
-
Aarhus University Hospital
Aarhus, Central Jutland, Denmark Recruiting
Study contacts
- Principal investigator: Tejs E Klug, MD, DMSc — Aarhus University Hospital
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transoral ultrasound versus standard clinical exam to diagnose peritonsillar abscess
This trial will test whether adding transoral ultrasound helps doctors tell which adults with suspected peritonsillar abscess need drainage.
-
Trimethoprim-sulfamethoxazole versus clindamycin for children with invasive MRSA infections
This will see if trimethoprim-sulfamethoxazole works as well as clindamycin to treat invasive MRSA infections in children aged 60 days to 18 years.
-
Understanding complicated infections in ear, nose, and throat
This study looks at how doctors treat complicated ear, nose, and throat infections to see if they can improve recovery times and outcomes for patients in Slovenia.
-
Suprazygomatic Maxillary Nerve Block for Kids After Tonsil Removal
This study tests whether giving a SZMN nerve block with or without medicine can reduce pain after tonsil surgery in children.
-
Families' views on antibiotic length and using a smartwatch to track children's symptoms
We will see if families are comfortable with shorter antibiotic courses and if a Garmin smartwatch can help track symptoms in children aged 4–17 with uncomplicated infections.
-
Comparing pain control methods after tonsil surgery in children
This study is testing whether long-lasting pain medicine like methadone works better than short-lasting options like fentanyl and hydromorphone for controlling pain in kids and teens after tonsil surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.